The kitchen spice most frequently used in Indian and Asian cuisine, 'Turmeric' can lend its hand in curing the most infectious respiratory disease, tuberculosis that has become drug-resistant.
In 2014, the global emergence of multidrug-resistant tuberculosis had made the treatment of tuberculosis much more challenging. But this study increases hope of developing new therapies for the treatment of this contagious disease.
Indian Scientist Abroad Come Up With New Strategy to Treat Multidrug-resistant Tuberculosis More Effectively
Bedaquilinea FDA approved drug to treat multidrug-resistant TB can be combined with Verpamil to help improve efficacy of the drug and lower its side effects says a new study.
Advertisement
‘Curcumin found in the spice turmeric has the potential to fight strains of tuberculosis that have developed resistance to antibiotics.’
Tweet it Now
Researchers from the University of Colorado School of Medicine in the US examined whether curcumin compound in turmeric that is hailed to be anti-cancerous and anti-inflammatory can have a potential effect against TB strains that have turned resistant to common antibiotics.
TB is caused by a bacteria called Mycobacterium Tuberculosis and the most commonly used antibiotics for its treatment are isoniazid and rifampicin.
![]()
Multidrug resistant tuberculosis occurs due to the bacterial resistance for the first line anti-TB drugs. Bedaquiline a miracle drug has the potential to save many lives and eradicate the infection.
Curcumin in turmeric has shown to act against the causative TB strain by stimulating macrophages, immune cells of the body. This inhibited the activation of a cellular molecule called nuclear factor-kappa B.
"Our study has provided basic evidence that curcumin protects against Mycobacterium tuberculosis infection in human cells. The protective role of curcumin to fight drug-resistant tuberculosis still needs confirmation, but if validated, curcumin may become a novel treatment to modulate the host immune response to overcome drug-resistant tuberculosis," said Dr Xiyuan Bai, lead author of the study published in the journal Respirology.
Source: Medindia
'Miracle Drug' Bedaquiline on Trial for Multidrug Resistance Tuberculosis (MDR-TB)
Multidrug resistant tuberculosis occurs due to the bacterial resistance for the first line anti-TB drugs. Bedaquiline a miracle drug has the potential to save many lives and eradicate the infection.
Advertisement
Curcumin in turmeric has shown to act against the causative TB strain by stimulating macrophages, immune cells of the body. This inhibited the activation of a cellular molecule called nuclear factor-kappa B.
"Our study has provided basic evidence that curcumin protects against Mycobacterium tuberculosis infection in human cells. The protective role of curcumin to fight drug-resistant tuberculosis still needs confirmation, but if validated, curcumin may become a novel treatment to modulate the host immune response to overcome drug-resistant tuberculosis," said Dr Xiyuan Bai, lead author of the study published in the journal Respirology.
Source: Medindia
Paired Effect of Curcumin and Omega-3-fatty Acids To Be Tested For Diabetes Prevention
Curcumin and omega-3-fats reduce systemic inflammation and has an effect on the body's insulin secretion and function, possibly benefiting diabetics.
Advertisement
 Turmeric – Indian Spice can Help Treat Oral Cancer, Good for Oral Health tooThe antioxidants in turmeric help suppress the activity of human papillomavirus (HPV), which promote the development of cervical and oral cancers. | Advertisement
|
Advertisement
Recommended Reading
Latest Respiratory Disease News
In South Africa, the cases of tuberculosis continue to rise making it as the primary cause of ill health and mortality.
Among patients with influenza, unnecessary prescription of antibiotics is found to have a significant impact on the growing threat of antimicrobial resistance.
India is left with 32 months (2025) to end tuberculosis and Nigeria is left with 92 months (2030) respectively.
Globally every year tuberculosis affects more than 10 million people. India contributes to 30% of the global tuberculosis burden.
People suffering from asthma or Chronic obstructive pulmonary disease (COPD) might one day benefit from new treatments that trigger bitter taste receptors.